North America Cartilage Repair Market By Modality (Cell Based - Chondrocyte Transplantation, Growth Factor; Non-Cell-Based - Tissue Scaffolds Systems, Cell-Free Composites, Application (Hyaline Cartilage, Fibrocartilage), Treatment Type (Palliative - Viscosupplementation, Debridement & Lavage; Intrinsic Repair Stimulus), Site Outlook (Knee - Arthroscopic Chondroplasty, Autologous Chondrocyte, Osteochondral Grafts, Cell-based Cartilage Resurfacing, Microfracture)

North America Cartilage Repair Market By Modality (Cell Based - Chondrocyte Transplantation, Growth Factor; Non-Cell-Based - Tissue Scaffolds Systems, Cell-Free Composites, Application (Hyaline Cartilage, Fibrocartilage), Treatment Type (Palliative - Viscosupplementation, Debridement & Lavage; Intrinsic Repair Stimulus), Site Outlook (Knee - Arthroscopic Chondroplasty, Autologous Chondrocyte, Osteochondral Grafts, Cell-based Cartilage Resurfacing, Microfracture)

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

Date of Publication 06-02-2019 | Number of Pages - 98 | Format - PDF

Chapter 1.    Market Scope & Methodology
1.1    Market Definition
1.2    Objectives
1.3    Market Scope
1.4    Segmentation
1.4.1    North America Cartilage Repair Market, by Modality
1.4.2    North America Cartilage Repair Market, by Treatment type
1.4.3    North America Cartilage Repair Market, by Application
1.4.1    North America Cartilage Repair Market, by Site outlook
1.4.2    North America Cartilage Repair Market, by Country
1.5    Methodology for the research
Chapter 2.    Market Overview
2.1    Introduction
2.1.1    Overview
2.1.2    Market Composition and Scenario
2.1.3    Players Outlook for the Market
2.2    Key Factors Impacting the Market
2.2.1    Market Drivers
2.2.2    Market Restraints
Chapter 3.    North America Cartilage Repair Market by Modality
3.1.1    North America Cell-Based Market by Country
3.1.1.1    North America Cartilage Repair Market by Cell-Based Type
3.1.1.1.1    North America Chondrocyte Transplantation Market by Country
3.1.1.1.2    North America Growth Factor Technology Market by Country
3.1.2    North America Non-Cell-Based Market by Country
3.1.2.1    North America Cartilage Repair Market by Non-Cell-Based Type
3.1.2.1.1    North America Tissue Scaffolds Market by Country
3.1.2.1.2    North America Cell-Free Composites Market by Country
Chapter 4.    North America Cartilage Repair Market by Treatment Type
4.1.1    North America Intrinsic Repair Stimulus Market by Country
4.1.2    North America Palliative Market by Country
4.1.2.1    North America Cartilage Repair Market by Palliative Type
4.1.2.1.1    North America Debridement & Lavage Market by Country
4.1.2.1.2    North America Viscosupplementation Market by Country
Chapter 5.    North America Cartilage Repair Market by Application
5.1.1    North America Fibrocartilage Market by Country
5.1.2    North America Hyaline Cartilage Market by Country
Chapter 6.    North America Cartilage Repair Market by Site Outlook
6.1.1    North America Knee Cartilage Repair Market by Country
6.1.1.1    North America Cartilage Repair Market by Knee Cartilage Repair Type
6.1.1.1.1    North America Microfracture Market by Country
6.1.1.1.2    North America Arthroscopic Chondroplasty Market by Country
6.1.1.1.3    North America Autologous Chondrocyte Market by Country
6.1.1.1.4    North America Osteochondral Grafts Transplantation Market by Country
6.1.1.1.5    North America Cell-based Cartilage Resurfacing Market by Country
6.1.1.1.6    North America Other Knee Cartilage Repair Type Market by Country
6.1.2    North America Other Site Outlook Market by Country
Chapter 7.    North America Cartilage Repair Market by Country
7.1    USA Cartilage Repair Market
7.1.1    USA Cartilage Repair Market by Modality
7.1.1.1    USA Cartilage Repair Market by Cell-Based Type
7.1.1.2    USA Cartilage Repair Market by Non-Cell-Based Type
7.1.2    USA Cartilage Repair Market by Treatment Type
7.1.2.1    USA Cartilage Repair Market by Palliative Type
7.1.3    USA Cartilage Repair Market by Application
7.1.4    USA Cartilage Repair Market by Site Outlook
7.1.4.1    USA Cartilage Repair Market by Knee Cartilage Repair Type
7.2    Canada Cartilage Repair Market
7.2.1    Canada Cartilage Repair Market by Modality
7.2.1.1    Canada Cartilage Repair Market by Cell-Based Type
7.2.1.2    Canada Cartilage Repair Market by Non-Cell-Based Type
7.2.2    Canada Cartilage Repair Market by Treatment Type
7.2.2.1    Canada Cartilage Repair Market by Palliative Type
7.2.3    Canada Cartilage Repair Market by Application
7.2.4    Canada Cartilage Repair Market by Site Outlook
7.2.4.1    Canada Cartilage Repair Market by Knee Cartilage Repair Type
7.3    Mexico Cartilage Repair Market
7.3.1    Mexico Cartilage Repair Market by Modality
7.3.1.1    Mexico Cartilage Repair Market by Cell-Based Type
7.3.1.2    Mexico Cartilage Repair Market by Non-Cell-Based Type
7.3.2    Mexico Cartilage Repair Market by Treatment Type
7.3.2.1    Mexico Cartilage Repair Market by Palliative Type
7.3.3    Mexico Cartilage Repair Market by Application
7.3.4    Mexico Cartilage Repair Market by Site Outlook
7.3.4.1    Mexico Cartilage Repair Market by Knee Cartilage Repair Type
7.4    Rest of North America Cartilage Repair Market
7.4.1    Rest of North America Cartilage Repair Market by Modality
7.4.1.1    Rest of North America Cartilage Repair Market by Cell-Based Type
7.4.1.2    Rest of North America Cartilage Repair Market by Non-Cell-Based Type
7.4.2    Rest of North America Cartilage Repair Market by Treatment Type
7.4.2.1    Rest of North America Cartilage Repair Market by Palliative Type
7.4.3    Rest of North America Cartilage Repair Market by Application
7.4.4    Rest of North America Cartilage Repair Market by Site Outlook
7.4.4.1    Rest of North America Cartilage Repair Market by Knee Cartilage Repair Type
Chapter 8.    Company Profiles
8.1    B. Braun Melsungen AG.
8.1.1    Company Overview
8.1.2    Financial Analysis
8.1.3    Segmental Analysis
8.1.4    Research & Development Expense
8.2    Smith & Nephew Plc.
8.2.1    Company Overview
8.2.2    Financial Analysis
8.2.3    Segmental and Regional analysis
8.2.4    Research & Development Expense
8.3    Stryker Corporation
8.3.1    Company Overview
8.3.2    Financial Analysis
8.3.3    Segmental Analysis
8.3.4    Research & Development Expense
8.4    Johnsons & Johnsons
8.4.1    Company Overview
8.4.2    Financial Analysis
8.4.3    Segmental & Revenue Analysis
8.4.4    Research & Development Expense
8.5    Vericel Corporation
8.5.1    Company Overview
8.5.2    Financial Analysis
8.5.3    Research & Development Expense
8.6    Osiris Therapeutics Inc.
8.6.1    Company Overview
8.6.2    Financial Analysis
8.6.3    Research & Development Expense
8.7    Collagen solutions Plc.
8.7.1    Company Overview
8.7.2    Financial Analysis
8.7.3    Regional Analysis
8.7.4    Research & Development Expense
8.8    Arthrex Inc.
8.8.1    Company Overview
8.9    Zimmer Biomet Holdings Inc.
8.9.1    Company Overview
8.9.2    Financial Analysis
8.9.3    Segmental and Regional analysis
8.9.4    Research & Development
8.1    Anika Therapeutics, Inc.
8.10.1    Company Overview
8.10.2    Financial Analysis
8.10.3    Segmental and Regional analysis
8.10.4    Research & Development


Share



Purchase Report

 1500
 1800
 2520

Special Pricing & Discounts

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities